LYTIR

Insider · SEC Form 4 · Director

JENKINS GEORGE M

In the 12 months to Nov 8, 2026, on the open market: sold $7.7M of PVLA. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $7.7M in total.Sep: Insider sales $4.2MOct: Insider sales $3.6MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $7.7M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. PVLASold: PALVELLA THERAPEUTICS, INC. Oct 14, 2026 7,174 shares filed Oct 14, 2026 6 transactions 10b5-1 plan filing $886K
  2. PVLASold: PALVELLA THERAPEUTICS, INC. Oct 13, 2026 7,174 shares filed Oct 14, 2026 6 transactions 10b5-1 plan filing $935K
  3. PVLASold: PALVELLA THERAPEUTICS, INC. Oct 12, 2026 13,152 shares filed Oct 14, 2026 5 transactions 10b5-1 plan filing $1.8M
  4. PVLASold: PALVELLA THERAPEUTICS, INC. Sep 15, 2026 1,777 shares filed Sep 15, 2026 3 transactions 10b5-1 plan filing $267K
  5. PVLASold: PALVELLA THERAPEUTICS, INC. Sep 14, 2026 13,352 shares filed Sep 15, 2026 3 transactions 10b5-1 plan filing $2.0M
  6. PVLASold: PALVELLA THERAPEUTICS, INC. Sep 11, 2026 12,371 shares filed Sep 15, 2026 3 transactions 10b5-1 plan filing $1.9M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.